Antibiotic Susceptibility Testing Market Size Estimated to Reach $4.5 Billion by 2026

Antibiotic Susceptibility Testing Market Overview Antibiotic Susceptibility Testing Market size is estimated to reach $4.5 billion by 2026, growing at a CAGR of 5.5% during the forecast period 2021-2026. Antimicrobial susceptibility testing is a procedure that is performed in a medical laboratory by professionals for identifying the antimicrobial regimen. Antibiotic susceptibility testing (AST) formulates a profile of empiric therapy for the proper management of a patient’s health. It assists in the judgment of therapy services supply by hospitals and clinics all over the world to prevent infectious diseases. It also guides the physician in making the right drug choice for the respective infections. Increase in the adoption of antibiotic susceptibility testing in medical laboratory, growing demand for minimum inhibitory concentration in antibiotic susceptibility testing, and rise in the prevalence of infections across the world are the factors that are set to drive the growth of the Antibiotic Susceptibility Testing Market for the period 2021-2026.

Key Takeaways

Geographically, North American Antibiotic Susceptibility Testing Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing demand for antibiotic susceptibility testing to drive empiric therapy.
The growing adoption of manual antimicrobial susceptibility testing products in a medical laboratory is driving the manual antimicrobial susceptibility testing products segment.
The complex regulatory frameworks is one of the major factors that is said to reduce the growth of the Antibiotic Susceptibility Testing Market.
Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Antibiotic Susceptibility Testing Market report.

Antibiotic Susceptibility Testing Market Segment Analysis-By Product

The Antibiotic Susceptibility Testing Market based on the Product can be further segmented into the Automated Laboratory Instruments, Culture and Growth Media, Manual Antimicrobial Susceptibility Testing Products, and Consumables. The Manual Antimicrobial Susceptibility Testing Products segment held the largest share in 2020 owing to the factors such as growing incidences of antibacterial resistance, rise in the adoption of manual antimicrobial susceptibility testing products in a medical laboratory, and increase in innovative product launches. The rise in the adoption of susceptibility testing disks in developing nations is driving the growth of the Antibiotic Susceptibility Testing Market. The Automated Laboratory Instruments segment is estimated to be the fastest-growing segment with a CAGR of 6.3% over the period 2021-2026. This growth is owing to the factors such as technological advancements in medical laboratory equipment, rising awareness about advanced laboratory automation systems for achieving true minimum inhibitory concentration, and growing demand for miniaturizing process equipment for empiric therapy.

Antibiotic Susceptibility Testing Market Segment Analysis-By Application

The Antibiotic Susceptibility Testing Market based on the Application can be further segmented into Drug Discovery and Development, Epidemiology, Clinical Diagnostics, and Others. The Clinical Diagnostics segment held the largest share in 2020 owing to the factors such as rise in the procedural volume of clinical diagnostic tests, increase in the prevalence of infectious diseases, and the growing emphasis on effective and early disease diagnosis. The introduction of various technologically advanced susceptibility testing products in developed nations is driving the growth of the Antibiotic Susceptibility Testing Market. The Drug Discovery segment is estimated to be the fastest-growing segment with a CAGR of 6.1% over the period 2021-2026. This growth is owing to the factors such as the growing application of antibiotic susceptibility testing in developing new drugs and increase in the adoption of automated laboratory instruments in drug discovery.

Antibiotic Susceptibility Testing Market Segment Analysis-By Geography

North America held the largest share with 31% of the overall market in 2020. The growth in this segment is owing to the factors such as increase in the demand for antibiotic susceptibility testing to drive empiric therapy, rise in the prevalence of infectious diseases, and growing research and development activities by the key players. The rise in the adoption of antibiotic susceptibility testing in a medical laboratory is driving the growth of the Antibiotic Susceptibility Testing Market. Asia-Pacific is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as rising number of epidemic outbreaks caused by infectious pathogens, growing demand for minimum inhibitory concentration in antibiotic susceptibility testing conducted in a medical laboratory, and increase in the awareness initiatives for antimicrobial resistance.

Antibiotic Susceptibility Testing Market Drivers

Rise in the Awareness Initiatives for Antimicrobial Resistance.

Healthcare authorities across the world are becoming more aware of the significance of antimicrobial susceptibility testing to ensure the efficacy and safety of various antibiotic susceptibility testing methods. Many non-profit organizations are also creating awareness to support the early diagnosis, recognition, and treatment of antibiotic resistance, which is driving the growth of the Antibiotic Susceptibility Testing Market.

Increase in the Prevalence of Several Infectious Diseases.

The increase in the number of epidemic outbreaks caused by infectious pathogens such as Neisseria meningitides, Streptococcus pneumonia, Neisseria gonorrhoeae, Haemophilus influenza, and Salmonella serotype Typhi are propelling the demand for minimum inhibitory concentration in antimicrobial susceptibility testing, which in turn is driving the growth of the Antibiotic Susceptibility Testing Market.

Antibiotic Susceptibility Testing Market Challenges

Complex Regulatory Frameworks.

The Food and Drug Administration (FDA) establishes several breakpoints when drug manufacturers submit new drug applications, which increase the time lapse between the approval of new antimicrobial agents and the inclusion of these antimicrobial agents in antimicrobial susceptibility testing. This is one of the major factors that is estimated to reduce the growth of the Antibiotic Susceptibility Testing Market.

Antibiotic Susceptibility Testing Market Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Antibiotic Susceptibility Testing Market. Key companies of this market are Thermo Fisher Scientific, Roche Diagnostics Limited, Merck Group, Bio-Rad, Accelerate Diagnostics Inc, Alifax, Synbiosis, MP Biomedicals, QuantaMatrix Inc, and Becton, Dickinson and Company among others.

Acquisitions/Product Launches:

In November 2019, Becton, Dickinson and Company has launched its latest advancement in combating antimicrobial resistance (AMR) with new analytics integrated into the company's connected medication management platform that identifies when a potentially ineffective antibiotic has been prescribed.
In August 2019, Alifax has launched a groundbreaking new solution for rapid bacteria identification that provides antimicrobial susceptibility and resistance tests in six hours, based on the rapid phenotypical method and requires minimal manual work.
In June 2019, Thermo Fisher Scientific has launched an automated system for antimicrobial susceptibility testing to provide the medical laboratory with accurate results and for safeguarding future patient care through successful antimicrobial stewardship.